Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with liver and metabolic diseases. The company is dedicated to addressing unmet medical needs through its proprietary drug candidates, which target key pathways involved in liver health and metabolic function. Terns is committed to advancing its pipeline of novel therapeutics, leveraging its expertise in drug development and a strong scientific foundation. With a focus on collaboration and innovation, Terns aims to improve the lives of patients suffering from chronic liver diseases and related conditions.